Literature DB >> 1450612

Effects of calcium channel blocking and atrial stimulation on QT time during hyper- and normocalcemia in man.

C Behrmann1, M Runge, J D Ringe.   

Abstract

We investigated how calcium channel blocking agents modify the known decrease of QT time with increasing heart rate and calcium level. Furthermore, we examined how the influence of calcium channel blocking agents is modulated by atrial stimulation. To answer these questions, we measured the QT time both at a spontaneous heart rate and during atrial stimulation with 90 and 110 beats/min before and after intravenous administration of 5 mg verapamil in 23 patients with primary hyperparathyroidism, pre- and postoperatively. Atrial stimulation increased the frequency-related standard values of QT time. The spontaneous heart rate (HR) was influenced by neither the calcium level nor verapamil. The statistically significant correlations QT vs. HR and QT vs. Ca were reduced by verapamil, which indicated its influence. However, this effect did not achieve statistical significance.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1450612     DOI: 10.1007/bf00180433

Source DB:  PubMed          Journal:  Clin Investig        ISSN: 0941-0198


  17 in total

1.  Cardiac calcium channels and their control by neurotransmitters and drugs.

Authors:  W Trautwein; A Cavalié
Journal:  J Am Coll Cardiol       Date:  1985-12       Impact factor: 24.094

Review 2.  Relationship between electrocardiogram and electrolytes.

Authors:  B Surawicz
Journal:  Am Heart J       Date:  1967-06       Impact factor: 4.749

3.  Therapeutic implications of slow-channel blockade in cardiocirculatory disorders.

Authors:  G Ellrodt; C Y Chew; B N Singh
Journal:  Circulation       Date:  1980-10       Impact factor: 29.690

4.  Extreme hypercalcemia and electrocardiographic changes.

Authors:  P S Douglas; K A Carmichael; P M Palevsky
Journal:  Am J Cardiol       Date:  1984-09-01       Impact factor: 2.778

5.  Cardiac manifestations of hyperparathyroidism, with presentation of a previously unreported arrhythmia.

Authors:  D M Voss; E H Drake
Journal:  Am Heart J       Date:  1967-02       Impact factor: 4.749

6.  Verapamil preserves myocardial contractility in the hereditary cardiomyopathy of the Syrian hamster.

Authors:  J L Rouleau; L H Chuck; G Hollosi; P Kidd; R E Sievers; J Wikman-Coffelt; W W Parmley
Journal:  Circ Res       Date:  1982-03       Impact factor: 17.367

Review 7.  Calcium channel blocking agents in the treatment of cardiovascular disorders. Part I: Basic and clinical electrophysiologic effects.

Authors:  E M Antman; P H Stone; J E Muller; E Braunwald
Journal:  Ann Intern Med       Date:  1980-12       Impact factor: 25.391

8.  Comparison of equal-weight oral dosages of verapamil hydrochloride and diltiazem hydrochloride in patients with mild to moderate hypertension.

Authors:  J W Hollifield; J J Heusner; M DesChamps; J Gray; D A Spyker; K E Peace; B Dickson
Journal:  Clin Pharm       Date:  1988-02

9.  Influence of heart rate and inhibition of autonomic tone on the QT interval.

Authors:  S Ahnve; H Vallin
Journal:  Circulation       Date:  1982-03       Impact factor: 29.690

10.  Electrophysiologic and hemodynamic effects of verapamin. Correlation with plasma drug concentrations.

Authors:  L M Mangiardi; R J Hariman; R G McAllister; V Bhargava; B Surawicz; R Shabetai
Journal:  Circulation       Date:  1978-02       Impact factor: 29.690

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.